Biotech IPOs Outperform AI Listings, Lead US Stock Rally in 2026
Biotech IPOs lead US markets in 2026, outpacing AI listings as healthcare innovation takes center stage over artificial intelligence.
Biotech IPOs lead US markets in 2026, outpacing AI listings as healthcare innovation takes center stage over artificial intelligence.
NEXTDC shares surged after the company secured significant new data center contracts, highlighting strong demand and growth prospects.
Short positions on US stocks reached unprecedented levels amid mounting fears that AI hype may lead to a market correction.
Alphabet shares gained on a report that Google is developing a new chip to enhance AI efficiency, potentially lowering costs and intensifying…
Nvidia spearheaded a chipmaker surge that lifted US stocks, with the S&P 500 and Nasdaq rebounding from a broad selloff as investors…
Bristol-Myers Squibb teams up with Nvidia to create an AI factory for drug development, marking a major push into AI-driven pharmaceutical research.
CleanSpark stock rallied on news of a landmark $6.6 billion data-center lease deal, underscoring the company's strategic shift toward AI infrastructure and…
Netflix options traders are positioning bullishly ahead of earnings, signaling optimism for subscriber growth and a potential stock rebound.
First fusion energy IPO surges over 80% on debut, signaling strong demand for next-generation nuclear technology despite commercial viability remaining years away.
Apple's lawsuit against OpenAI over alleged IP infringement threatens to disrupt the startup's plans to launch an iPhone rival, injecting uncertainty into…
Apple’s $600 billion market cap jump highlights a sharp rotation from AI stocks into large-cap tech safety.
Saudi tech firm NourNet picks Goldman Sachs and HSBC to lead its IPO, highlighting growing advisory opportunities in Middle East equity markets.